Boehringer Ingelheim Licenses DoubleTwist's Industry-Leading Clustering and Alignment Tools.Business Editors/Medical Writers OAKLAND, Calif.--(BW HealthWire)--June 20, 2001 DoubleTwist, Inc. today announced that Boehringer Ingelheim International GmbH has licensed DoubleTwist's industry-leading Clustering and Alignment Tools (CAT). These computational Having to do with calculations. Something that is "highly computational" requires a large number of calculations. tools enable users to quickly cluster and align align (  līn),v to move the teeth into their proper positions to conform to the line of occlusion. large volumes of expressed sequence tags An expressed sequence tag or EST is a short sub-sequence of a transcribed spliced nucleotide sequence (either protein-coding or not). They may be used to identify gene transcripts, and are instrumental in gene discovery and gene sequence determination. (ESTs) and mRNA sequences into full-length gene sequences suitable for gene indexing and other applications in drug discovery. In addition, CAT automatically detects and provides statistical correction of sequencing and cloning cloning: see clone. To make a product that functions like another. See clone. See also cloning software. errors, and resolves gene variants by isolating and analyzing alternative splice forms. "As one of the global players in pharmaceutical research, we are very pleased that Boehringer Ingelheim has joined the growing list of pharmaceutical and biotechnology firms that have made our CAT product an industry standard," said Simon Tomlinson, general manager, DoubleTwist Europe. "As researchers attempt to mine the mountains of raw data emerging from large-scale sequencing efforts, CAT provides an unparalleled ability to group and extend ESTs and to enable the automatic resolution of alternative splice forms." "We chose CAT not only for the quality of the technology, but also because we feel that DoubleTwist as a global company is best positioned to support the discovery efforts of our global research units," said Professor Bernd Wetzel, head of Corporate Division Research and Nonclinical Development at Boehringer Ingelheim. DoubleTwist, Inc. provides genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. information and bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the tools to the life sciences industry. The Company's mission is to empower empower verb To encourage or provide a person with the means or information to become involved in solving his/her own problems the life scientist by simplifying and accelerating genomic research. The Boehringer Ingelheim group of companies, with headquarters in Ingelheim (Germany), is one of the 20 leading pharmaceutical firms in the world and reported revenues of almost EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 6 billion in 2000. Substantial research and development, production, and distribution facilities are located around the globe. In 2000 Boehringer Ingelheim spent EUR 1.0 billion on R&D, equivalent to 16% of total sales. As a research-driven company, Boehringer Ingelheim has R&D centres in Argentina, Austria, Canada, Germany, Japan and the USA. For more information on Boehringer Ingelheim please see also the international Internet website www.boehringer-ingelheim.com Note to Editors: DoubleTwist and the DoubleTwist logo are trademarks of DoubleTwist, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion